3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
4
Multiple Myeloma
2
Vaccinia
1
Transplant-Related Hematologic Malignancy
1
Recurrence
1
Prostatic Neoplasms
1
Oligodendroglioma
1
Neoplasms
1
Medulloblastoma
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Kidney Neoplasms
1
Hodgkin Disease
1
Glioma
1
Carcinoma, Hepatocellular
1
Brain Neoplasms
1
Interventions
Cisplatin
17
Gemcitabine
13
Radiotherapy, Intensity-Modulated
11
Magnetic Resonance Spectroscopy
8
toripalimab
7
Specimen Handling
7
Platinum
5
Drug Therapy
5
Capecitabine
5
1,2-diaminocyclohexaneplatinum II citrate
5
Radiotherapy
4
Nivolumab
4
spartalizumab
3
sintilimab
3
camrelizumab
3
anlotinib
3
Immune Checkpoint Inhibitors
3
Docetaxel
3
Radiation
2
Phantoms, Imaging
2
Ipilimumab
2
Immunoglobulin G
2
Disulfides
2
Carboplatin
2
CTLA-4 Antigen
2
Biopsy
2
18-O-demethylcervinomycin A2
2
tislelizumab
1
relatlimab
1
penpulimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Nasopharyngeal Carcinoma
×
Granulocyte-Macrophage Colony-Stimulating Factor
×
90 days
×
Clear all
No trials found.